Serum Metabolomics of Retinoblastoma: Assessing the Differential Serum Metabolic Signatures of Unilateral and Bilateral Patients
暂无分享,去创建一个
[1] Fan Yang,et al. Cancer metabolites: promising biomarkers for cancer liquid biopsy , 2023, Biomarker Research.
[2] Chang Sik Cho,et al. Inhibition of protein arginine deiminase II suppresses retinoblastoma in orthotopic transplantation in mice , 2023, Oncology reports.
[3] Z. Nwosu,et al. Uridine-derived ribose fuels glucose-restricted pancreatic cancer , 2023, Nature.
[4] Shi Qiu,et al. Small molecule metabolites: discovery of biomarkers and therapeutic targets , 2023, Signal Transduction and Targeted Therapy.
[5] A. Valente,et al. NMR-Based Metabolomics Demonstrates a Metabolic Change during Early Developmental Stages from Healthy Infants to Young Children , 2023, Metabolites.
[6] Puneet,et al. Association of altered metabolic profiles and long non-coding RNAs expression with disease severity in breast cancer patients: analysis by 1H NMR spectroscopy and RT-q-PCR , 2023, Metabolomics.
[7] Jide Tian,et al. The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19 , 2023, Biomedicines.
[8] R. Shetty,et al. Lack of Retinoblastoma Protein Shifts Tumor Metabolism from Glycolysis to OXPHOS and Allows the Use of Alternate Fuels , 2022, Cells.
[9] S. Tripathi,et al. Dissecting the molecular mechanisms of producing biofuel and value-added products by cadmium tolerant microalgae as sustainable biorefinery approach , 2022, Chemical Engineering Journal.
[10] Meenakshi Sharma,et al. Overexpression of bacteriophage T4 and T7 endolysins differentially regulate the metabolic fingerprint of host Escherichia coli. , 2022, International journal of biological macromolecules.
[11] Zhibin Wang,et al. Lactate metabolism in human health and disease , 2022, Signal Transduction and Targeted Therapy.
[12] B. Sitter,et al. Elevated Serum Lactate in Glioma Patients: Associated Factors , 2022, Frontiers in Oncology.
[13] R. Shetty,et al. Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced Tumors , 2022, Cells.
[14] R. Chammas,et al. Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells , 2022, Frontiers in Immunology.
[15] Xiao-Fan Wang,et al. Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression , 2022, Nature Cell Biology.
[16] Dinesh Kumar,et al. Serum Metabolic Disturbances in Lung Cancer Investigated through an Elaborative NMR-Based Serum Metabolomics Approach , 2022, ACS omega.
[17] Y. Bao,et al. Vitamin C Intake and Cancers: An Umbrella Review , 2022, Frontiers in Nutrition.
[18] Xianqun Fan,et al. Monitoring Retinoblastoma by Machine Learning of Aqueous Humor Metabolic Fingerprinting. , 2021, Small methods.
[19] Liwen Zhang,et al. The two sides of creatine in cancer. , 2021, Trends in cell biology.
[20] D. Dunger,et al. Metabolomics in early life and the association with body composition at age 2 years , 2021, Pediatric obesity.
[21] J. Xia,et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights , 2021, Nucleic Acids Res..
[22] M. V. Vander Heiden,et al. Metabolomics in cancer research and emerging applications in clinical oncology , 2021, CA: a cancer journal for clinicians.
[23] B. Firestein,et al. Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation , 2021, Cells.
[24] O. Ijare,et al. The Leloir Cycle in Glioblastoma: Galactose Scavenging and Metabolic Remodeling , 2021, Cancers.
[25] F. N. Leeuwen,et al. Amino Acid Depletion Therapies: Starving Cancer Cells to Death , 2021, Trends in Endocrinology & Metabolism.
[26] Liyan Liu,et al. Serum metabolite signatures of epithelial ovarian cancer based on targeted metabolomics. , 2021, Clinica chimica acta; international journal of clinical chemistry.
[27] Min Su,et al. The cancer metabolic reprogramming and immune response , 2021, Molecular cancer.
[28] J. Jeon,et al. Untargeted Metabolomics and Polyamine Profiling in Serum before and after Surgery in Colorectal Cancer Patients , 2020, Metabolites.
[29] J. Decock,et al. Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors , 2020, Frontiers in Oncology.
[30] T. Spector,et al. A reference map of potential determinants for the human serum metabolome , 2020, Nature.
[31] R. Powers,et al. Quantitative NMR-Based Biomedical Metabolomics: Current Status and Applications , 2020, Molecules.
[32] H. Biebermann,et al. Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and -resistant retinoblastoma cells , 2020, Laboratory Investigation.
[33] Hui Peng,et al. MULTIFACETED ROLE OF BRANCHED-CHAIN AMINO ACID METABOLISM IN CANCER , 2020, Oncogene.
[34] N. Laforgia,et al. Metabolomics Applications in Children: A Right Way to Go , 2020, Metabolites.
[35] Hongming Miao,et al. Metabolism in tumor microenvironment: Implications for cancer immunotherapy , 2020, MedComm.
[36] G. Minchiotti,et al. Proline Metabolism in Tumor Growth and Metastatic Progression , 2020, Frontiers in Oncology.
[37] B. Faubert,et al. Metabolic reprogramming and cancer progression , 2020, Science.
[38] P. Kaiser. Methionine Dependence of Cancer , 2020, Biomolecules.
[39] Jayoung Kim,et al. Identification of Metabolic Alterations in Breast Cancer Using Mass Spectrometry-Based Metabolomic Analysis , 2020, Metabolites.
[40] I. Sagap,et al. Global metabolomics profiling of colorectal cancer in Malaysian patients , 2020, BioImpacts : BI.
[41] S. Sivanand,et al. Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer. , 2020, Cancer cell.
[42] D. Tennant,et al. New aspects of amino acid metabolism in cancer , 2019, British Journal of Cancer.
[43] David S. Wishart,et al. Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis , 2019, Current protocols in bioinformatics.
[44] J. Manzo-Merino,et al. Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches , 2019, Front. Oncol..
[45] B. V. Van Tine,et al. Innate and adaptive resistance mechanisms to arginine deprivation therapies in sarcoma and other cancers , 2019, Cancer drug resistance.
[46] A. León-Del-Río. Biotin in metabolism, gene expression, and human disease , 2019, Journal of inherited metabolic disease.
[47] W. Barczak,et al. Vitamin C as a Modulator of the Response to Cancer Therapy , 2019, Molecules.
[48] Dinesh Kumar,et al. NMR Based Metabolomics: An Exquisite and Facile Method for Evaluating Therapeutic Efficacy and Screening Drug Toxicity. , 2018, Current Topics in Medicinal Chemistry.
[49] Karthik Raman,et al. Metabolite systems profiling identifies exploitable weaknesses in retinoblastoma , 2018, FEBS letters.
[50] J. Xiong. Fatty Acid Oxidation in Cell Fate Determination. , 2018, Trends in biochemical sciences.
[51] B. Kreikemeyer,et al. Arginine-Depleting Enzymes – An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies , 2018, Cellular Physiology and Biochemistry.
[52] J. L. Izquierdo-García,et al. Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner , 2018, Cancer & metabolism.
[53] V. Umashankar,et al. Insights on ornithine decarboxylase silencing as a potential strategy for targeting retinoblastoma. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[54] Martin Wilson,et al. Metabolic profiling of the three neural derived embryonal pediatric tumors retinoblastoma, neuroblastoma and medulloblastoma, identifies distinct metabolic profiles , 2018, Oncotarget.
[55] F. Hallböök,et al. Heterogeneity in retinoblastoma: a tale of molecules and models , 2017, Clinical and Translational Medicine.
[56] M. Touvier,et al. NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer. , 2017, International journal of epidemiology.
[57] S. Kitajima,et al. Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation , 2017, Cancer science.
[58] C. Livi,et al. Abstract 2515: Understanding metabolic dysfunction in retinoblastoma development , 2017 .
[59] J. Vadgama,et al. Lactate, a Neglected Factor for Diabetes and Cancer Interaction , 2016, Mediators of inflammation.
[60] D. Fukumura,et al. Arginine dependence of tumor cells: targeting a chink in cancer’s armor , 2016, Oncogene.
[61] F. Mussai,et al. Molecular basis and current strategies of therapeutic arginine depletion for cancer , 2016, International journal of cancer.
[62] N. Dyson. RB1: a prototype tumor suppressor and an enigma , 2016, Genes & development.
[63] S. Liao,et al. Metabolomics Reveals Dynamic Metabolic Changes Associated with Age in Early Childhood , 2016, PloS one.
[64] Martin Wilson,et al. Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups , 2015, British Journal of Cancer.
[65] W. D. Cress,et al. THE RETINOBLASTOMA PROTEIN: A MASTER TUMOR SUPPRESSOR ACTS AS A LINK BETWEEN CELL CYCLE AND CELL ADHESION. , 2014, Cell health and cytoskeleton.
[66] R. Sinha,et al. Dietary methionine restriction inhibits prostatic intraepithelial neoplasia in TRAMP mice , 2014, The Prostate.
[67] M. Tempero,et al. HR‐MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer , 2014, NMR in biomedicine.
[68] S. Taylor-Robinson,et al. Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans , 2014, Hepatology.
[69] G. Hwang,et al. Noninvasive Diagnosis and Evaluation of Curative Surgery for Gastric Cancer by Using NMR-based Metabolomic Profiling , 2014, Annals of Surgical Oncology.
[70] I. Amelio,et al. Serine and glycine metabolism in cancer☆ , 2014, Trends in biochemical sciences.
[71] L. Satyanarayana,et al. Childhood cancer incidence in India: A review of population-based cancer registries , 2014, Indian Pediatrics.
[72] G. Cevenini,et al. High Doses of Ascorbate Kill Y79 Retinoblastoma Cells In vitro , 2013 .
[73] S. Moco,et al. Metabolomics perspectives in pediatric research , 2013, Pediatric Research.
[74] Juan Mendizabal-Zubiaga,et al. GABA release by hippocampal astrocytes , 2012, Front. Comput. Neurosci..
[75] E. Fukusaki,et al. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. , 2012, Biomedical chromatography : BMC.
[76] F. Sotgia,et al. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. , 2011, The international journal of biochemistry & cell biology.
[77] Adam Ertel,et al. Evidence for a stromal-epithelial “lactate shuttle” in human tumors , 2011, Cell cycle.
[78] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[79] P. Mcgeer,et al. Astrocytes are GABAergic cells that modulate microglial activity , 2011, Glia.
[80] A. Tsirigos,et al. Ketones and lactate “fuel” tumor growth and metastasis , 2010, Cell cycle.
[81] B. Delage,et al. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer , 2010, International journal of cancer.
[82] David S. Wishart,et al. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data , 2010, Nucleic Acids Res..
[83] A. Vingrys,et al. Glutamate metabolic pathways and retinal function , 2009, Journal of neurochemistry.
[84] O. Feron,et al. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[85] A. Bordey,et al. GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches. , 2009, Physiology.
[86] David S. Wishart,et al. MetaboAnalyst: a web server for metabolomic data analysis and interpretation , 2009, Nucleic Acids Res..
[87] Martin Wilson,et al. High resolution magic angle spinning 1H NMR of childhood brain and nervous system tumours , 2009, Molecular Cancer.
[88] J. Sage,et al. Cellular mechanisms of tumour suppression by the retinoblastoma gene , 2008, Nature Reviews Cancer.
[89] K. Knudsen,et al. Tailoring to RB: tumour suppressor status and therapeutic response , 2008, Nature Reviews Cancer.
[90] David S. Wishart,et al. Quantitative metabolomics using NMR , 2008 .
[91] J. H. Kim,et al. Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma. , 2007, Oncology reports.
[92] M. C. Angulo,et al. Target cell-specific modulation of neuronal activity by astrocytes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[93] A. Smilde,et al. Centering, scaling, and transformations: improving the biological information content of metabolomics data , 2006, BMC Genomics.
[94] J. Lindon,et al. Scaling and normalization effects in NMR spectroscopic metabonomic data sets. , 2006, Analytical chemistry.
[95] M. Kalloniatis,et al. Creatine transporter localization in developing and adult retina: importance of creatine to retinal function. , 2005, American journal of physiology. Cell physiology.
[96] H. Lim,et al. Production of GABA by cultured hippocampal glial cells , 2004, Neurochemistry International.
[97] D. Wheatley,et al. Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth , 2003, British Journal of Cancer.
[98] R. Schipper,et al. Distribution Patterns of Ornithine Decarboxylase in Cells and Tissues: Facts, Problems, and Postulates , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[99] Dragan Maric,et al. Persistent Activation of GABAAReceptor/Cl− Channels by Astrocyte-Derived GABA in Cultured Embryonic Rat Hippocampal Neurons , 2000 .
[100] B. S. Winkler. Glycolytic and oxidative metabolism in relation to retinal function , 1981, The Journal of general physiology.
[101] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[102] OUP accepted manuscript , 2021, Nucleic Acids Research.
[103] António S. Barros,et al. NMR metabolomics of human lung tumours reveals distinct metabolic signatures for adenocarcinoma and squamous cell carcinoma. , 2015, Carcinogenesis.
[104] Wei Liu,et al. Proline metabolism and cancer. , 2012, Frontiers in bioscience.
[105] J. Steyaert,et al. PP2A activity is controlled by methylation and regulates oncoprotein expression in melanoma cells: a mechanism which participates in growth inhibition induced by chloroethylnitrosourea treatment. , 2008, International journal of oncology.